NZ508323A - Neisseria meningitidis BASB029 polynucleotides and polypeptides and methods for their production - Google Patents

Neisseria meningitidis BASB029 polynucleotides and polypeptides and methods for their production

Info

Publication number
NZ508323A
NZ508323A NZ508323A NZ50832399A NZ508323A NZ 508323 A NZ508323 A NZ 508323A NZ 508323 A NZ508323 A NZ 508323A NZ 50832399 A NZ50832399 A NZ 50832399A NZ 508323 A NZ508323 A NZ 508323A
Authority
NZ
New Zealand
Prior art keywords
polypeptides
methods
polynucleotides
production
basb029
Prior art date
Application number
NZ508323A
Other languages
English (en)
Inventor
Jean-Louis Ruelle
Original Assignee
Smithkline Beecham Biolog S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10831992&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ508323(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Biolog S filed Critical Smithkline Beecham Biolog S
Publication of NZ508323A publication Critical patent/NZ508323A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1217—Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
NZ508323A 1998-05-13 1999-05-07 Neisseria meningitidis BASB029 polynucleotides and polypeptides and methods for their production NZ508323A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810276.7A GB9810276D0 (en) 1998-05-13 1998-05-13 Novel compounds
PCT/EP1999/003255 WO1999058683A2 (en) 1998-05-13 1999-05-07 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS)

Publications (1)

Publication Number Publication Date
NZ508323A true NZ508323A (en) 2002-10-25

Family

ID=10831992

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ508323A NZ508323A (en) 1998-05-13 1999-05-07 Neisseria meningitidis BASB029 polynucleotides and polypeptides and methods for their production

Country Status (23)

Country Link
US (3) US6780419B1 (https=)
EP (2) EP1078063B1 (https=)
JP (2) JP4707832B2 (https=)
KR (4) KR20100019461A (https=)
CN (1) CN1322127C (https=)
AT (1) ATE311457T1 (https=)
AU (1) AU750032B2 (https=)
BR (1) BR9910396A (https=)
CA (1) CA2328403C (https=)
CY (1) CY1105676T1 (https=)
CZ (1) CZ299612B6 (https=)
DE (1) DE69928658T2 (https=)
DK (1) DK1078063T3 (https=)
ES (1) ES2252946T3 (https=)
GB (1) GB9810276D0 (https=)
HU (1) HUP0102479A3 (https=)
IL (2) IL139613A0 (https=)
NO (2) NO326994B1 (https=)
NZ (1) NZ508323A (https=)
PL (1) PL197449B1 (https=)
TR (1) TR200003347T2 (https=)
WO (1) WO1999058683A2 (https=)
ZA (1) ZA200006523B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
AU1979599A (en) * 1998-01-14 1999-08-02 Chiron S.P.A. (neisseria meningitidis) antigens
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
JP4812942B2 (ja) 1999-02-26 2011-11-09 ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル ＣＧモチーフを含むオリゴヌクレオチドを用いるＮｅｉｓｓｅｒｉａ抗原殺菌活性の増強
GB9916529D0 (en) * 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
RU2281956C2 (ru) 1999-10-29 2006-08-20 Чирон С.Р.Л. Антигенные пептиды neisseria
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
PT2289545T (pt) * 2000-01-17 2016-09-06 Glaxosmithkline Biologicals Sa Vacina de omv suplementada contra meningococos
PL216780B1 (pl) * 2000-01-25 2014-05-30 Univ Queensland Of Santa Lucia Wyizolowane białka zawierające konserwatywne obszary antygenu powierzchniowego NhhA z Neisseria meningitidis, białka fuzyjne, kompozycja farmaceutyczna, przeciwciało monoklonalne lub wiążący antygen fragment przeciwciała monoklonalnego, wyizolowany kwas nukleinowy, konstrukt ekspresyjny, komórka gospodarza, sposób wytwarzania rekombinowanego białka, sposób wykrywania N. meningitidis w próbce biologicznej, sposób diagnozowania zakażenia N. meningitidis oraz sposób wykrywania N. meningitidis w próbce biologicznej uzyskanej od pacjenta oraz zastosowanie wyizolowanego białka, białka fuzyjnego i konstruktu ekspresyjnego
ES2281409T3 (es) 2000-02-28 2007-10-01 Novartis Vaccines And Diagnostics S.R.L. Expresion heterologa de proteinas de neisseria.
BR0211494A (pt) 2001-07-27 2004-08-17 Chiron Srl Adesinas de meningococo nada, app e orf 40
EP1524991A1 (en) 2002-08-02 2005-04-27 GlaxoSmithKline Biologicals S.A. Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria
HUE031886T2 (en) 2002-10-11 2017-08-28 Glaxosmithkline Biologicals Sa Polypeptide vaccines for extensive protection against hypervirulent meningococcal lines
CN103357002A (zh) 2003-10-02 2013-10-23 诺华疫苗和诊断有限公司 多种脑膜炎球菌血清群的液体疫苗
US7459930B2 (en) * 2006-11-14 2008-12-02 Micron Technology, Inc. Digital calibration circuits, devices and systems including same, and methods of operation
GB0700562D0 (en) 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
GB0916570D0 (en) 2009-09-21 2009-10-28 Royal Holloway & Bedford New C Method
EP2545068B8 (en) 2010-03-11 2018-03-21 GlaxoSmithKline Biologicals S.A. Immunogenic composition or vaccine against gram-negative bacterial, for example neiserial, infection or disease
ES2642184T3 (es) * 2012-01-05 2017-11-15 Deutsches Krebsforschungszentrum Péptidos para su uso en el tratamiento y diagnóstico de cánceres positivos a IDH1 R132H
ES2801054T3 (es) 2016-07-27 2021-01-08 Prysmian Spa Cinta de fibra óptica flexible

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769240A (en) * 1980-09-15 1988-09-06 Bactex, Inc. Pili of neisseria and vaccine compositions containing same
US4702911A (en) * 1985-09-27 1987-10-27 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
JPH01125328A (ja) 1987-07-30 1989-05-17 Centro Natl De Biopreparados 髄膜炎菌ワクチン
FR2682041B1 (fr) * 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.
US6245337B1 (en) * 1994-08-25 2001-06-12 Washington University Haemophilus adherence and penetration proteins
US6121037A (en) * 1994-10-18 2000-09-19 Stojiljkovic; Igor Bacterial hemoglobin receptor genes
US5646259A (en) * 1995-03-24 1997-07-08 St. Louis University DNA encoding haemophilus adhesion proteins
US6265567B1 (en) * 1995-04-07 2001-07-24 University Of North Carolina At Chapel Hill Isolated FrpB nucleic acid molecule
CU22559A1 (es) * 1996-01-17 1999-05-03 Ct Ingenieria Genetica Biotech Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
AU1979599A (en) * 1998-01-14 1999-08-02 Chiron S.P.A. (neisseria meningitidis) antigens
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
JP2003518363A (ja) * 1999-04-30 2003-06-10 カイロン エセ．ピー．アー． 保存されたナイセリア抗原

Also Published As

Publication number Publication date
HUP0102479A2 (hu) 2001-10-28
ES2252946T3 (es) 2006-05-16
CZ299612B6 (cs) 2008-09-17
EP1621623A2 (en) 2006-02-01
TR200003347T2 (tr) 2001-06-21
ZA200006523B (en) 2001-11-12
KR20080070073A (ko) 2008-07-29
CZ20004202A3 (en) 2001-05-16
BR9910396A (pt) 2001-10-30
HUP0102479A3 (en) 2004-10-28
IL139613A (en) 2014-03-31
US6780419B1 (en) 2004-08-24
JP2002514424A (ja) 2002-05-21
NO20090955L (no) 2001-01-11
EP1078063B1 (en) 2005-11-30
PL197449B1 (pl) 2008-03-31
NO326994B1 (no) 2009-03-30
KR100673674B1 (ko) 2007-01-23
DE69928658T2 (de) 2006-06-14
DK1078063T3 (da) 2006-04-03
WO1999058683A2 (en) 1999-11-18
EP1621623A3 (en) 2009-02-18
KR20010043571A (ko) 2001-05-25
JP4707832B2 (ja) 2011-06-22
ATE311457T1 (de) 2005-12-15
CN1309707A (zh) 2001-08-22
CY1105676T1 (el) 2010-12-22
CA2328403C (en) 2013-11-05
DE69928658D1 (de) 2006-01-05
AU750032B2 (en) 2002-07-11
NO20005696L (no) 2001-01-11
WO1999058683A9 (en) 2002-05-02
WO1999058683A3 (en) 2000-04-06
GB9810276D0 (en) 1998-07-15
EP1078063A2 (en) 2001-02-28
NO20005696D0 (no) 2000-11-10
PL345281A1 (en) 2001-12-03
CN1322127C (zh) 2007-06-20
JP2010166921A (ja) 2010-08-05
CA2328403A1 (en) 1999-11-18
KR20100019461A (ko) 2010-02-18
US20090093622A1 (en) 2009-04-09
US20040265332A1 (en) 2004-12-30
AU4142099A (en) 1999-11-29
KR20060076789A (ko) 2006-07-04
IL139613A0 (en) 2002-02-10
HK1036300A1 (en) 2001-12-28
KR100897951B1 (ko) 2009-05-18

Similar Documents

Publication Publication Date Title
NZ508323A (en) Neisseria meningitidis BASB029 polynucleotides and polypeptides and methods for their production
EP0554383A4 (https=)
CA2316808A1 (en) Transgenic rabbit that expresses a functional human lipoprotein (a)
EP0849361A3 (en) Novel ligands of the neuropeptide receptor HFGAN72
PT1056856E (pt) Factor neurotrofico cliliar modificado processo de preparacao e sua utilizacao
GR3025596T3 (en) Compositions and methods for identifying biologically active molecules.
WO2001098334A3 (en) Streptococcus antigens
HUP0202863A2 (hu) Oligoszacharid receptormimetikumot kifejező rekombináns mikroorganizmusok
DE69727142D1 (de) Verwendung eines bpi proteinproduktes als antithrombotisches mittel
ATE320811T1 (de) Verwendung von beta-blatt mimetika als protease und kinase hemmer und alshemmer eines transkriptionsfaktors
AU7226301A (en) Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
TR199600116A2 (tr) Bir delta-5,7 sterol, delta-7 reduktaz aktivitesi, delta 7-red proteinine sahip bir a. talian proteini icin dna sirasi kodlamasi, üretim islemi, dönüstürülmüs maya türü, kullanimlari.
AU6453596A (en) Fungicidal mixtures
EP1969003B8 (en) Uses of a NEUROTROPHIC FACTOR PROTEIN
GB9526178D0 (en) Novel polynuceotides and polypeptides in pathogenic mycobacteria and their use as diagnostics,vaccines and targets for chemotherapy
AP1502A (en) Genes and proteins, and their uses.
ATE272648T1 (de) Glycokonjugate von 20(s)-camptothecin
NO20000731D0 (no) Neisseria-lactodweeinbindingsprotein
ATE301194T1 (de) Beta-defensine
BR9707776A (pt) Utilização da il-7 no tratamento das doenças autoimunes em especial o diabetes mellitus dependente de insulina
WO2001083722A3 (en) Enzymes useful for treating and methods for treating mps-vi and cells lines for producing such enzymes recombinantly
AU5909600A (en) 17867, a novel human aminopeptidase
GB0120022D0 (en) Conjugate
WO1999030670A3 (en) Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
WO2002086067A3 (en) Mycobacterial sulfation pathway proteins and methods of use thereof

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired